Trademark: 77345125
Word
KUROGRAFT
Status
Dead
Status Code
710
Status Date
Friday, July 7, 2017
Serial Number
77345125
Registration Number
3882001
Registration Date
Tuesday, November 30, 2010
Mark Type
4000
Filing Date
Wednesday, December 5, 2007
Published for Opposition
Tuesday, February 9, 2010
Cancellation Date
Friday, July 7, 2017

Trademark Owner History
Kuros Biosurgery AG - Original Registrant

Classifications
5 Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement
10 Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
KUROS GRAFT

Trademark Events
Jul 7, 2017
Cancelled Sec. 8 (6-Yr)
Nov 30, 2010
Registered-Principal Register
Oct 21, 2010
Petition To Director - Change Basis - Granted
Oct 21, 2010
1(B) Basis Deleted; Proceed To Registration
Oct 19, 2010
Notice Of Allowance Cancelled
Oct 20, 2010
Case Assigned To Intent To Use Paralegal
Oct 20, 2010
Assigned To Petition Staff
Oct 19, 2010
Teas Post Publication Amendment Received
Oct 19, 2010
Teas Petition To Amend Basis Received
May 4, 2010
Noa Mailed - Sou Required From Applicant
Feb 9, 2010
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2010
Published For Opposition
Jan 7, 2010
Law Office Publication Review Completed
Jan 7, 2010
Approved For Pub - Principal Register
Dec 17, 2009
Teas/Email Correspondence Entered
Dec 17, 2009
Correspondence Received In Law Office
Dec 17, 2009
Teas Response To Office Action Received
Jul 21, 2009
Notification Of Non-Final Action E-Mailed
Jul 21, 2009
Non-Final Action E-Mailed
Jul 21, 2009
Non-Final Action Written
May 23, 2009
Teas/Email Correspondence Entered
May 23, 2009
Correspondence Received In Law Office
May 21, 2009
Assigned To Lie
May 21, 2009
Teas Request For Reconsideration Received
May 21, 2009
Ex Parte Appeal-Instituted
May 21, 2009
Jurisdiction Restored To Examining Attorney
May 21, 2009
Exparte Appeal Received At Ttab
Nov 21, 2008
Notification Of Final Refusal Emailed
Nov 21, 2008
Final Refusal E-Mailed
Nov 21, 2008
Final Refusal Written
Nov 7, 2008
Teas/Email Correspondence Entered
Nov 7, 2008
Correspondence Received In Law Office
Nov 7, 2008
Teas Response To Suspension Inquiry Received
Sep 25, 2008
Notification Of Letter Of Suspension E-Mailed
Sep 25, 2008
Letter Of Suspension E-Mailed
Sep 25, 2008
Suspension Letter Written
Sep 16, 2008
Teas/Email Correspondence Entered
Sep 16, 2008
Correspondence Received In Law Office
Sep 16, 2008
Teas Response To Office Action Received
Mar 17, 2008
Notification Of Non-Final Action E-Mailed
Mar 17, 2008
Non-Final Action E-Mailed
Mar 17, 2008
Non-Final Action Written
Mar 14, 2008
Teas Voluntary Amendment Received
Mar 14, 2008
Assigned To Examiner
Dec 11, 2007
Notice Of Pseudo Mark Mailed
Dec 10, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24